首页|阿司匹林和低分子肝素预防手足创伤骨折患者术后静脉血栓栓塞的临床研究

阿司匹林和低分子肝素预防手足创伤骨折患者术后静脉血栓栓塞的临床研究

扫码查看
目的 观察阿司匹林与低分子肝素预防手足创伤骨折患者术后静脉血栓栓塞(VTE)和对远端循环的改善作用.方法 回顾性选取手足创伤骨折手术患者分为对照组和试验组.对照组给予阿司匹林肠溶片,每次0.1 g,qd;试验组给予低分子量肝素钙注射液注射液,每次4 000 U,bid,连续治疗12 d.比较2组术后VET发生率、凝血功能、血流动力学指标、远端侧支循环情况以及药物不良反应发生情况.结果 试验组和对照组患者分别入组60例.试验组和对照组术后深静脉血栓发生率分别为5.00%和3.33%,肺栓塞发生率均为1.67%,在统计学上差异均无统计学意义(均P>0.05).治疗后,试验组和对照组外周血活化部分凝血活酶时间(APTT)分别为(35.01±5.96)和(36.82±6.15)s,凝血酶原时间(PT)分别为(14.95±1.54)和(15.32±1.63)s,纤维蛋白原(FIB)分别为(3.97±1.25)和(4.36±1.02)g·L-1,D-二聚体(D-D)分别为(309.69±56.55)和(319.03±55.32)μg·L-1,全血黏度(WBV)分别为(13.26±3.80)和(12.26±3.61)mPa·s-1,血浆黏度(PV)分别为(1.76±0.35)和(1.77±0.43)mPa·s-1,红细胞压积(HCT)分别为(60.20±7.05)%和(58.60±6.71)%,在统计学上差异均无统计学意义(均P>0.05).治疗后,试验组和对照组流速(Vmax)分别为(54.27±6.64)和(51.18±5.67)cm·s-1,阻力指数(RI)参数分别为 0.59±0.13 和 0.65±0.15,在统计学上差异均有统计学意义(均P<0.05).试验组与对照组术后恶心呕吐、出血、注射部位血肿等药物不良反应比较,药物不良反应总发生率在统计学上差异无统计学意义(P>0.05).结论 阿司匹林与低分子肝素预防手足创伤骨折患者术后VET的疗效无显著差异,但低分子肝素在改善远端侧支循环方面效果更佳.
Clinical trial of aspirin and low molecular weight heparin for prevention of venous thromboembolism in patients with hand and foot trauma fractures after operation
Objective To observe the postoperative effects of aspirin and low-molecular-weight heparin(LMWH)in preventing venous thromboembolism(VTE)and improving distal circulation in patients with hand and foot trauma fractures.Methods Retrospectivey selected patients undergoing hand and foot trauma fracture surgery into control and treatment groups.The control group received enteric-coated aspirin,0.1 g per dose,once daily;the treatment group received subcutaneous injection of calcium-enoxaparin,4 000 U per dose,twice daily,for continuous treatment for 12 days.The incidence of VTE,coagulation function,hemorheological parameters,distal collateral circulation,and drug adverse reactions were compared between the two groups.Results There were 60 patients in each of the treatment and control groups.The incidence of postoperative deep vein thrombosis was 5.00%in the treatment group and 3.33%in the control group,while the incidence of pulmonary embolism was 1.67%in both groups,with no statistically significant differences(all P>0.05).After treatment,the activated partial thromboplastin time(APTT)in the treatment and control groups were(35.01±5.96)and(36.82±6.15)s,prothrombin time(PT)were(14.95±1.54)and(15.32±1.63)s;fibrinogen(FIB)were(3.97±1.25)and(4.36±1.02)g·L-1;D-dimer(D-D)were(309.69±56.55)and(319.03±55.32)μg·L-1;whole blood viscosity(WBV)were(13.26±3.80)and(12.26±3.61)mPa·s-1;plasma viscosity(PV)were(1.76±0.35)and(1.77±0.43)mPa·s-1,hematocrit(HCT)were(60.20±7.05)%and(58.60±6.71)%,with no statistically significant differences(all P>0.05).After treatment,the flow rates(Vmax)in the treatment and control groups were(54.27±6.64)and(51.18±5.67)cm·s-1;resistance indices(RI)were 0.59±0.13 and 0.65±0.15,showing statistical significance(all P<0.05).Comparison of drug adverse reactions such as nausea,vomiting,bleeding,and injection site hematoma between the treatment and control groups showed no statistically significant difference in the overall incidence of adverse drug reactions(P>0.05).Conclusion There was no significant difference in the efficacy of aspirin and LMWH in preventing postoperative VTE in patients with hand and foot trauma fractures,but LMWH demonstrated better improvement in distal collateral circulation.

aspirinlow molecular weight heparinhand-foot trauma fracturepostoperative venous thrombosisdistal circulation

孙立、刘荣、李勇、王加刚

展开 >

苏州市第九人民医院骨科,江苏苏州 215200

阿司匹林 低分子肝素 手足创伤骨折 术后静脉血栓 远端循环

2024

中国临床药理学杂志
中国药学会

中国临床药理学杂志

CSTPCD北大核心
影响因子:1.91
ISSN:1001-6821
年,卷(期):2024.40(12)
  • 13